FDA Approves First Oral Pill for Thalassemia Anaemia

The FDA has approved a new oral pill called mitapivat, also known as Aqvesme, for treating anaemia in adults with thalassemia.

This is a big deal because thalassemia patients have traditionally relied on blood transfusions and other treatments.

Mitapivat works by helping red blood cells last longer and function better, which can reduce the need for transfusions.

Experts are excited because this pill could make life much easier for thalassemia patients, especially in India, where many people have this condition.

The pill could also help manage the high demand for blood transfusions in the country.

Overall, this new treatment offers hope for better and more sustainable care for thalassemia patients.